2016 Champalimaud Vision Award

The 2016 António Champalimaud Vision Award recognized ARVO member Carol Mason, PhD, along with three other researchers, for their extraordinary findings in the relationship between the brain and the eyes — research that opens up the potential development of new therapies to combat vision disorders. The Champalimaud Award — worth €1 million (U.S. $1.3 million) —  is the highest distinction in ophthalmology and visual science.

Meet the recipients
 
John FlanaganJohn Flanagan, PhD
Harvard Medical School,
Department of Cell Biology

The broad interest of his lab is to understand how cell-cell signaling molecules regulate the development and regeneration of neuronal connections. The researchers use a broad range of approaches, including biochemical, molecular, cellularand in vivo studies. Learn more

 

Christine Holt 2

Christine Holt, PhD 
University of Cambridge 
Department of Physiology, Development and Neuroscience

Holt’s laboratory is investigating how nerve connections are formed and maintained. Learn more 

 



Carol Mason Carol Mason, PhD 
Columbia University
Department of Pathology and Cell Biology

Mason’s research program seeks to understand the mechanisms underlying the development of the visual system, and in the past, the cerebellum. Learn more

 



Carla Shatz, PhD Carla Shatz
Stanford University
Neurosciences Institute

Shatz is Sapp Family Provostial Professor of Biology and Neurobiology and the David Starr Jordan Director of Bio-X, Stanford University’s pioneering interdisciplinary biosciences program that brings together faculty from across the entire university — clinicians, biologists, engineers,physicists, computer scientists —to unlock the secrets of the human body. Learn more


The collective efforts of Flanagan, Holt, Mason and Shatz have shone light on the connection between the two fundamental organs responsible for vision — the eye and the brain. Their groundbreaking work has greatly advanced the understanding of the visual system and offer hope in fighting vision disorders with neurological therapies.

In the year that commemorates the 10th anniversary of the António Champalimaud Vision Award, the prize-giving ceremony was presided over by the president of the Portuguese Republic, Marcelo Rebelo de Sousa, PhD.

ARVO members can hear about the researchers’ work firsthand at the ARVO/Champalimaud Award Lecture on May 9 at the ARVO 2017 Annual Meeting in Baltimore, Md.

Advertisement
Eversight april 3